Mohammed Al-Hijji
Overview
Explore the profile of Mohammed Al-Hijji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alnabti A, Abujalala S, Al-Hijji M, Othman K, Rafie I, Suwaidi J, et al.
Int J Cardiol
. 2025 Feb;
424:133029.
PMID: 39894314
Background: Transcatheter aortic valve implantation (TAVI) is a therapeutic modality for high-surgical-risk patients with severe aortic stenosis. This study describes the outcomes of TAVI performed in Qatar. Methods: The Qatar...
2.
Kaddoura R, Al-Hijji M
Eur Heart J
. 2024 Sep;
45(38):3904-3907.
PMID: 39258907
No abstract available.
3.
Rahhal A, Hamamyh T, Chapra A, Zaza K, Najim M, Hemadneh M, et al.
Front Cardiovasc Med
. 2024 Jun;
11:1383669.
PMID: 38832317
Background: Acute coronary syndrome (ACS) remains a risk factor for heart failure (HF). Therefore, we aimed to assess the cardioprotective role of sodium-glucose cotransporter-2 (SGLT2) inhibitors post-ACS in patients with...
4.
Al-Asmi S, Kaddoura R, Abdelghani M, Ahmed A, Maaly C, Alzaeem H, et al.
Heart Views
. 2024 Jan;
24(4):179-187.
PMID: 38188715
Background: Transcatheter mitral valve repair (TMVr), using MitraClip, is a safe and effective procedure for severe mitral valve regurgitation (MR). However, the therapeutic results of MitraClip in Qatar remain to...
5.
Armario X, Carron J, Simpkin A, Elhadi M, Kennedy C, Abdel-Wahab M, et al.
JACC Cardiovasc Interv
. 2024 Jan;
17(3):374-387.
PMID: 38180419
Background: The COVID-19 pandemic adversely affected health care systems. Patients in need of transcatheter aortic valve replacement (TAVR) are especially susceptible to treatment delays. Objectives: This study sought to evaluate...
6.
Jalil S, Ahmed A, Abdalla M, Al-Hijji M
Eur Heart J Case Rep
. 2023 Nov;
7(11):ytad553.
PMID: 38025122
Background: Rheumatic fever is still a major cause of mitral valve (MV) stenosis in the developing world. Few patients with critical rheumatic MV stenosis can present with acute cardiogenic shock...
7.
8.
Kaddoura R, Bhattarai S, Abushanab D, Al-Hijji M
Am J Cardiol
. 2023 Sep;
207:159-169.
PMID: 37741106
This systematic review and meta-analysis aimed to investigate whether percutaneous mitral valve repair (PMVr) using MitraClip was more effective than surgery or medical therapy for long-term morbidity and mortality. We...
9.
Kaddoura R, Al-Badriyeh D, Abushanab D, Al-Hijji M
Curr Probl Cardiol
. 2023 Jun;
48(10):101889.
PMID: 37336309
Many questions were raised due to the divergent results between cardiovascular outcomes assessment of the MitraClip percutaneous therapy for heart failure patients with functional mitral regurgitation (COAPT) and multicenter study...
10.
Ahmed A, Mohammed N, Alzaeem H, Jalil S, Maaly C, Al-Hijji M
Heart Views
. 2023 May;
24(1):50-53.
PMID: 37124438
Cardiogenic shock (CS) in the setting of acute coronary syndrome carries detrimental consequences and high levels of mortality and morbidity if not managed promptly. Acute mitral regurgitation (MR) as a...